ICON Pre-Tax Profit Margin 2010-2025 | ICLR
Current and historical pre-tax profit margin for ICON (ICLR) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. ICON pre-tax profit margin for the three months ending March 31, 2025 was .
| ICON Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $8.19B | $0.83B | 10.11% |
| 2024-12-31 | $8.28B | $0.87B | 10.51% |
| 2024-09-30 | $8.31B | $0.81B | 9.72% |
| 2024-06-30 | $8.33B | $0.75B | 9.05% |
| 2024-03-31 | $8.23B | $0.71B | 8.61% |
| 2023-12-31 | $8.12B | $0.62B | 7.68% |
| 2023-09-30 | $8.02B | $0.57B | 7.07% |
| 2023-06-30 | $7.90B | $0.57B | 7.17% |
| 2023-03-31 | $7.82B | $0.57B | 7.33% |
| 2022-12-31 | $7.74B | $0.57B | 7.34% |
| 2022-09-30 | $7.66B | $0.53B | 6.93% |
| 2022-06-30 | $7.59B | $0.25B | 3.32% |
| 2022-03-31 | $6.52B | $0.21B | 3.22% |
| 2021-12-31 | $5.48B | $0.20B | 3.61% |
| 2021-09-30 | $4.36B | $0.22B | 5.12% |
| 2021-06-30 | $3.19B | $0.43B | 13.32% |
| 2021-03-31 | $2.94B | $0.39B | 13.27% |
| 2020-12-31 | $2.80B | $0.38B | 13.62% |
| 2020-09-30 | $2.76B | $0.38B | 13.65% |
| 2020-06-30 | $2.77B | $0.38B | 13.75% |
| 2020-03-31 | $2.85B | $0.43B | 15.18% |
| 2019-12-31 | $2.81B | $0.43B | 15.22% |
| 2019-09-30 | $2.76B | $0.41B | 15.01% |
| 2019-06-30 | $2.70B | $0.40B | 14.83% |
| 2019-03-31 | $2.65B | $0.38B | 14.18% |
| 2018-12-31 | $2.60B | $0.37B | 14.06% |
| 2018-09-30 | $2.37B | $0.35B | 14.84% |
| 2018-06-30 | $2.16B | $0.34B | 15.67% |
| 2018-03-31 | $1.95B | $0.33B | 17.11% |
| 2017-12-31 | $1.76B | $0.33B | 18.60% |
| 2017-09-30 | $1.74B | $0.32B | 18.53% |
| 2017-06-30 | $1.72B | $0.31B | 18.28% |
| 2017-03-31 | $1.70B | $0.31B | 18.26% |
| 2016-12-31 | $1.67B | $0.30B | 18.00% |
| 2016-09-30 | $1.64B | $0.29B | 17.80% |
| 2016-06-30 | $1.61B | $0.29B | 17.89% |
| 2016-03-31 | $1.59B | $0.29B | 17.95% |
| 2015-12-31 | $1.58B | $0.28B | 17.71% |
| 2015-09-30 | $1.56B | $0.26B | 16.52% |
| 2015-06-30 | $1.56B | $0.25B | 15.88% |
| 2015-03-31 | $1.54B | $0.23B | 14.72% |
| 2014-12-31 | $1.50B | $0.20B | 13.50% |
| 2014-09-30 | $1.46B | $0.19B | 13.02% |
| 2014-06-30 | $1.41B | $0.16B | 11.55% |
| 2014-03-31 | $1.37B | $0.14B | 10.30% |
| 2013-12-31 | $1.44B | $0.12B | 8.41% |
| 2013-09-30 | $1.39B | $0.11B | 7.68% |
| 2013-06-30 | $1.34B | $0.10B | 7.09% |
| 2013-03-31 | $1.28B | $0.08B | 6.24% |
| 2012-12-31 | $1.21B | $0.07B | 5.64% |
| 2012-09-30 | $1.15B | $0.05B | 4.26% |
| 2012-06-30 | $1.10B | $0.02B | 2.17% |
| 2012-03-31 | $1.06B | $0.03B | 2.74% |
| 2011-12-31 | $1.02B | $0.03B | 2.83% |
| 2011-09-30 | $1.01B | $0.05B | 4.55% |
| 2011-06-30 | $1.00B | $0.07B | 6.83% |
| 2011-03-31 | $0.99B | $0.08B | 7.90% |
| 2010-12-31 | $0.99B | $0.09B | 9.49% |
| 2010-09-30 | $0.99B | $0.10B | 10.14% |
| 2010-06-30 | $0.98B | $0.11B | 11.42% |
| 2010-03-31 | $0.98B | $0.11B | 10.85% |
| 2009-12-31 | $0.89B | $0.11B | 11.84% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.829B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.550B | 26.36 |
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| Revvity (RVTY) | United States | $11.196B | 19.27 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.61 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Surgery Partners (SGRY) | United States | $2.473B | 32.17 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.62 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| OncoCyte (IMDX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |